Cargando…

Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

BACKGROUND: We investigated an association between the levels of plasma microRNA (miRNA)-21, -26a, and -29a-3p and treatment outcomes following transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). METHODS: A total of 198 patients with TACE-treated HCC were followed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Soon Sun, Cho, Hyo Jung, Nam, Ji Sun, Kim, Hyun Ji, Kang, Dae Ryong, Won, Je Hwan, Kim, Jinoo, Kim, Jai Keun, Lee, Jei Hee, Kim, Bo Hyun, Lee, Mi Young, Cho, Sung Won, Cheong, Jae Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729641/ https://www.ncbi.nlm.nih.gov/pubmed/29215815 http://dx.doi.org/10.3346/jkms.2018.33.e6

Ejemplares similares

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor
por: Lee, Song Yi, et al.
Publicado: (2018)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
por: Park, Kil Hyo, et al.
Publicado: (2015)

Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
por: Yoo, Sun Hong, et al.
Publicado: (2020)

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Chung, Sung Won, et al.
Publicado: (2021)

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Jae Seung, et al.
Publicado: (2021)

Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
por: Ji, Suk Kyeong, et al.
Publicado: (2008)

Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
por: Cho, EunJu, et al.
Publicado: (2014)

Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Sohn, Won, et al.
Publicado: (2020)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
por: Chung, Sung Won, et al.
Publicado: (2023)

Depiction of Viable Tumor in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Multiphasic Helical CT with Review of the Previous Serial CT Images
por: Jang, Kyung Mi, et al.
Publicado: (2005)

A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Kim, Ah ran, et al.
Publicado: (2015)

Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
por: Lee, In Joon, et al.
Publicado: (2019)

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Jeong, Shin Ok, et al.
Publicado: (2017)

Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
por: Lee, Hyung Soon, et al.
Publicado: (2019)

Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases
por: Yoo, Jeong-Ju, et al.
Publicado: (2014)

Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report
por: Kim, Shin Il, et al.
Publicado: (2016)

Adjuvant effect of herbal medicine on transarterial chemoembolization in patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Oh, Hyeon-Muk, et al.
Publicado: (2023)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Sang-Geun, et al.
Publicado: (2022)

Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma
por: Nouri, Yasir M., et al.
Publicado: (2019)

Acute Obstructive Cholangitis after Transarterial Chemoembolization: the Effect of Percutaneous Transhepatic Removal of Tumor Fragment
por: Choi, Kyu-Ho, et al.
Publicado: (2009)

Comparison of Drug Release and Pharmacokinetics after Transarterial Chemoembolization Using Diverse Lipiodol Emulsions and Drug-Eluting Beads
por: Choi, Jin Woo, et al.
Publicado: (2014)

Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Kim, Young Woon, et al.
Publicado: (2018)

Occupational dose and associated factors during transarterial chemoembolization of hepatocellular carcinoma using real-time dosimetry: A simple way to reduce radiation exposure
por: Kim, Hyoung Ook, et al.
Publicado: (2022)

Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
por: Kim, Min Jin, et al.
Publicado: (2015)

Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma: A case report
por: Son, Dong-Jun, et al.
Publicado: (2018)

Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization
por: Kim, Nam Hee, et al.
Publicado: (2019)

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study
por: Cho, Youn Zoo, et al.
Publicado: (2015)

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
por: Kim, Jihye, et al.
Publicado: (2019)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021)

Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
por: Lim, Ji Young, et al.
Publicado: (2020)

DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study
por: Song, Do Seon, et al.
Publicado: (2013)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
por: Yu, Su Jong, et al.
Publicado: (2023)

Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
por: Baek, Min Young, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3bj8u4hk6458orkgi0du71hs3r